Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus
Shang Jun-jie, Fang Liu, Bing Zhang, et al.
PeerJ (2021) Vol. 9, pp. e11128-e11128
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 83
Diabetes and gut microbiome
K. Fliegerová, Tiziana Maria Mahayri, Hana Sechovcová, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access | Times Cited: 2
Interkingdom signaling between gastrointestinal hormones and the gut microbiome
Xinyu Zhao, Ye Qiu, Lanfan Liang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
Nyan Abdalqadir, Khosrow Adeli
Microorganisms (2022) Vol. 10, Iss. 10, pp. 2061-2061
Open Access | Times Cited: 51
Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study
Chih-Yiu Tsai, Hsiu-Chen Lu, Yu‐Hsien Chou, et al.
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 49
Composition and diversity of gut microbiota in diabetic retinopathy
Jianhao Bai, Zhongqi Wan, Yuanyuan Zhang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 42
Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
Wenhui Liu, Zhiying Luo, Jiecan Zhou, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 41
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
Merlin C. Thomas, Melinda T. Coughlan, Mark E. Cooper
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 253-273
Open Access | Times Cited: 33
Gut microbiota and therapy for obesity and type 2 diabetes
Luyao Zhang, Pai Wang, Juan Huang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 15
Tilapia nilotica Head Lipids Improved Bone Loss by Regulating Inflammation and Serum Metabolism Through Gut Microbiota in Ovariectomized Rats
Yujie Zhu, Shucheng Liu, Fengfeng Mei, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 33
Gut microbiota and metabolites in diabetic retinopathy: Insights into pathogenesis for novel therapeutic strategies
Yue Cai, Yongbo Kang
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114994-114994
Open Access | Times Cited: 20
Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products
Fan Xia, Luping Wen, Bingchen Ge, et al.
World Journal of Diabetes (2021) Vol. 12, Iss. 8, pp. 1146-1163
Open Access | Times Cited: 33
Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review
Ruolin Li, Fereshteh Shokri, A. Rincón, et al.
Genes (2023) Vol. 14, Iss. 8, pp. 1572-1572
Open Access | Times Cited: 14
Baihu renshen decoction ameliorates type 2 diabetes mellitus in rats through affecting gut microbiota enhancing gut permeability and inhibiting TLR4/NF-κB-mediated inflammatory response
Bin Yao, Baochao Pan, Tian Tian, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 20
Gut Microbiota Dysbiosis in Diabetic Retinopathy—Current Knowledge and Future Therapeutic Targets
Dragoş Şerban, Ana Maria Dascălu, Andreea Letiția Arsene, et al.
Life (2023) Vol. 13, Iss. 4, pp. 968-968
Open Access | Times Cited: 11
The Effects of Cardioprotective Antidiabetic Therapy on Microbiota in Patients with Type 2 Diabetes Mellitus—A Systematic Review
Cristina Bică, Valeria-Anca Pietroșel, Teodor Salmen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7184-7184
Open Access | Times Cited: 11
Glucagon‐like peptide‐1 receptor agonist regulates fat browning by altering the gut microbiota and ceramide metabolism
Ke Lin, Chunyan Dong, Binyan Zhao, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 11
Anorexigenic and anti-inflammatory signaling pathways of semaglutide via the microbiota–gut––brain axis in obese mice
Rodrigo Soares da Silva, Igor Henrique Rodrigues de Paiva, Ingrid Prata Mendonça, et al.
Inflammopharmacology (2024)
Closed Access | Times Cited: 4
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists
Jake Chen, Cooper Me, Coughlan Mt
Diabetes & Metabolism (2025), pp. 101641-101641
Closed Access
Mendelian randomization analysis reveals a causal effect of Streptococcus salivarius on diabetic retinopathy through regulating host fasting glucose
Jingjing Li, Gongwei Zheng, Dingping Jiang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 7
Open Access | Times Cited: 3
Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD
Ahmad Moolla, Toryn Poolman, Nantia Othonos, et al.
JHEP Reports (2025) Vol. 7, Iss. 5, pp. 101363-101363
Open Access
Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1683-1693
Open Access | Times Cited: 9
Alterations in the Gut Microbiota in Pregnant Women with Pregestational Type 2 Diabetes Mellitus
Yuan Ren, Lilan Hao, Juntao Liu, et al.
mSystems (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 8
Recent Insights into the Role of Gut Microbiota in Diabetic Retinopathy
Jinghua Jiao, Honghua Yu, Litong Yao, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 6929-6938
Open Access | Times Cited: 20
Compound dietary fiber and high-grade protein diet improves glycemic control and ameliorates diabetes and its comorbidities through remodeling the gut microbiota in mice
Yinhua Ni, Aqian Zheng, Yating Hu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top